Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HOPE | BXDC |
|---|---|---|
| Price | $13.57 | $17.22 |
| Change today | ▼ 0.80% | ▼ 0.29% |
| Market cap | $1.73B | $1.73B |
| Return, 3 months | +2.7% | -17.5% |
| Return, year to date | +27.9% | – |
| Return, 1 year | +27.7% | – |
| P/E (TTM) | 13.4 | -410.0 |
| P/B | 0.8 | 0.9 |
| P/E percentile vs own 5y | – | 93rd |
| Dividend yield | 4.13% | – |
| Revenue growth (YoY, latest qtr) | +56.4% | – |
| Net profit growth (YoY) | +233.5% | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 22.2% | – |
| Return on equity | 5.7% | – |
| Analyst target vs. price | +14.2% | +35.5% |
| Analyst buy share | 33% | 38% |
| RSI (14) | 44 | 24 |
| 30-day volatility | 15.7% | 26.1% |
| Max drawdown, 1 year | -14.9% | -22.9% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
